Download - WHOCC

QV03AC
QV03AE
QV03AF
Iron-chelating agents
Drugs for treatment of hyperkalemia and hyperphosphatemia
Detoxifying agents for antineopastic treatment
Mesna for i.v. administration, used for the prophylaxis of urothelial toxicity, should
be classified in this group. Mesna used as a mucolytic agent, however, is classified
in QR05CB - Mucolytics.
QV03AG
Drugs for treatment of hypercalcemia
Sodium cellulose phosphate should be classified here.
See also QM05 - Drugs for treatment of bone diseases.
QV03AH
Drugs for treatment of hypoglycemia
Oral preparations containing diazoxide for the treatment of hypoglycemia should be
classified in this group, while parenteral products used for treatment of
hypertension are classified in QC02DA.
QV03AK
QV03AM
QV03AN
QV03AX
Tissue adhesives
Drugs for embolisation
Medical gases
Other therapeutic products
Agents which cannot be classified in the preceding groups should be assigned to
this group.
QV03AZ
Nerve depressants
QV04
QV04B
DIAGNOSTIC AGENTS
URINE TESTS
QV04C
OTHER DIAGNOSTIC AGENTS
Only substances approved as drugs and used in vivo will be included in the ATCvet
classification system.
QV04CA
QV04CB
Tests for diabetes
Tests for fat absorption
177